Evidence map›Paper›PMID 24430572›Full record

ArticleJournal of human genetics2014

Mitochondrial haplotypes may modulate the phenotypic manifestation of the LHON-associated ND1 G3460A mutation in Chinese families.

Yanchun Ji, Min Liang, Juanjuan Zhang, Minglian Zhang, Jinping Zhu, Xiangjuan Meng, Sai Zhang, Min Gao, Fuxin Zhao, Qi-Ping Wei and 5 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Mitochondrial tRNAFrontiers in genetics · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Yanchun JiDepartment of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Min LiangDepartment of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Juanjuan Zhang1] Department of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China [2] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [3] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Minglian ZhangDepartment of Ophthalmology, Xingtai Eye Hospital, Xingtai, Hebei, China.
Jinping Zhu1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Xiangjuan Meng1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Sai Zhang1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Min Gao1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Fuxin Zhao1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Qi-Ping WeiDepartment of Ophthalmology, Dongfang Hospital, Beijing University of Chinese Medicine and Pharmacology, Beijing, China.
Pingping JiangDepartment of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Yi Tong1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Xiaoling Liu1] School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China [2] Attardi Institute of Mitochondrial Biomedicine, Wenzhou Medical University, Wenzhou, China.
Jun Qin MoDivision of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Min-Xin GuanDepartment of Genetics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Wenzhou Medical University · CNZhejiang University · CNBeijing University of Chinese Medicine · CNCincinnati Children's Hospital Medical Center · USHebei Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the pathophysiology of Leber's hereditary optic neuropathy (LHON), a cohort of 1164 Han Chinese subjects with LHON were screened for ND1 G3460A mutation. A total of 295 subjects from 16 Han Chinese families carrying the G3460A mutation underwent a clinical and genetic evaluation and molecular analysis of mitochondrial (mt)DNA. The incidence of G3460A mutation was 1.4% in this cohort of Chinese subjects with LHON. Twenty-seven (20 males/7 females) of 109 matrilineal relatives among 10 Chinese pedigrees carrying this mutation exhibited a wide range of severity and age-at-onset in visual impairment. Penetrances of optic neuropathy ranged from 7.1% to 50%, with the average of 24.5%. The age-at-onset of 27 affected matrilineal relatives varied from 10 to 40 years, with the average of 22 years. Molecular analysis identified the homoplasmic G3460A mutation and distinct sets of variants belonging to eight haplogroups. Haplogroup M with G3460A mutation was of higher frequency than those in controls. The penetrances of visual loss in families carrying mitochondrial DNA haplogroups A, B and M were higher than those in other families. Furthermore, haplogroup-specific variants tRNA(Ser(AGY)) A12223G, tRNA(Thr) G15927A and tRNA(Glu) A14693G may enhance the penetrance of visual loss in these families. The G3460A mutation occurred through recurrent origins and founder events in Chinese population. Mitochondrial modifiers may modulate the penetrance and expressivity of optic neuropathy among Chinese pedigrees carrying the G3460A mutation. Thus, our findings may provide new insights into the understanding of pathophysiology and valuable information on the management of LHON.

Indexed as

Genetic Predisposition to DiseaseAmino Acid SubstitutionAsian PeopleChinaCohort StudiesDiagnostic Techniques, OphthalmologicalDNA, MitochondrialDNA Mutational AnalysisFamilyFemaleGenome, MitochondrialHaplotypesHumansMaleMitochondriaMutationDNA, MitochondrialNADH DehydrogenaseNADH dehydrogenase subunit 1, humanRNA, Ribosomal

Identifiers

PMID24430572
OpenAlexW1971928640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.